Regulators inevitably stepped in. By 1984, the drug was listed as Schedule I in the US as well as a Class B drug in the united kingdom, which makes its manufacturing and distribution illegal entirely. In distinction, identification of ligands concentrating on multidomain receptor complexes such as being the GABAARs https://methaqualone-synthesis49360.tblogz.com/the-5-second-trick-for-methaqualone-43694127